Articles related to BIOMARKERS

In this study, dostarlimab combined with carboplatin-paclitaxel demonstrated a marked improvement in progression-free and overall survival among endometrial cancer patients, particularly those with genetic markers for dMMR and MSI-H.

As physicians, understanding the new biomarker legislation is crucial—it not only shapes insurance coverage but also influences clinical decision-making and patient access to precision medicine, potentially leading to more cost-effective and targeted care.

This pivotal research reveals that aMCI patients’ struggle with processing complex sentences could serve as an early indicator of Alzheimer’s, emphasizing the critical need for healthcare professionals to consider language proficiency in early diagnostic evaluations.

Explore the intersection of dietary intervention and biological aging: a fasting-mimicking diet presents a promising avenue for reducing age-related biomarkers and improving metabolic health, offering new strategies in disease prevention and patient care.

This longitudinal study offers an unprecedented look at the temporal changes in CSF and imaging biomarkers over two decades, providing clinicians with a detailed timeline of biomarker alterations that precede the clinical onset of Alzheimer’s disease, thereby paving the way for potential early diagnostic and therapeutic strategies.

This study illuminates the potential of preoperative circulating tumor DNA to redefine the approach to treating high-risk upper tract urothelial carcinoma, offering a nuanced tool for assessing the necessity of neoadjuvant chemotherapy and tailoring patient care.